AGTR1 and focal segmental glomerulosclerosis: This study also introduced a novel TRPC5 inhibitor, named AC1903 (see Section 3.2.2), which showed similar effects to ML204 in suppressing proteinuria, in both AT1R transgenic animals and a model of hypertension-induced FSGS.